The root cause of type 2 diabetes is not a single defect but two interlocking problems: your cells gradually stop responding to insulin (insulin resistance), and the insulin-producing cells in your pancreas eventually can’t keep up with the rising demand. These two processes feed each other over years, sometimes decades, before blood sugar climbs high enough to cross the diagnostic threshold. Understanding how this cycle works, and what drives it, reveals why some people develop type 2 diabetes and others don’t.
Today, roughly 589 million adults worldwide live with diabetes, about one in nine people. That number is projected to reach 853 million by 2050.
Insulin Resistance: Where It Starts
Insulin is the hormone that tells your cells to pull sugar out of the bloodstream and use it for energy. In type 2 diabetes, muscle, liver, and fat cells gradually lose their ability to respond to that signal. This isn’t an on-off switch. It’s a slow dimming that can take 35 to 40 years in the normoglycemic phase before blood sugar even begins to creep upward.
The primary trigger for this resistance, in most people, is the buildup of fat where it doesn’t belong. When excess calories accumulate as fat inside muscle and liver cells (rather than safely in fat tissue under the skin), those lipid byproducts physically interfere with the molecular chain of events insulin relies on. Think of insulin as a key and insulin receptors as locks on your cells. The fat byproducts essentially gum up the lock mechanism, so even when the key turns, the door doesn’t open properly. The result: glucose stays in the bloodstream instead of entering cells.
Inflammation compounds the problem. Excess body fat, particularly the deep visceral fat around your organs, acts like an active gland, pumping out inflammatory molecules. These molecules further jam the insulin signaling pathway in muscle, liver, and fat tissue. The more visceral fat you carry, the more inflammation, and the worse insulin resistance becomes.
How Fat in the Liver Drives Blood Sugar Up
Your liver plays a central role in blood sugar regulation. It stores sugar after meals and releases it between meals to keep your brain and muscles fueled. Insulin’s job is to tell the liver when to stop releasing sugar, because enough is already circulating. When fat accumulates inside liver cells, this “stop” signal gets blunted.
Researcher Roy Taylor’s twin cycle hypothesis describes how this unfolds. Chronic calorie surplus drives fat into the liver. Excess carbohydrates that can’t be stored as glycogen get converted to fat through a process the liver ramps up when insulin levels are high. The fattier the liver becomes, the less responsive it is to insulin’s signal to stop producing glucose. Fasting blood sugar starts rising. The body compensates by making even more insulin, which paradoxically drives more fat production in the liver. A vicious cycle locks in.
There’s a strange paradox at the heart of this process. The fatty liver becomes resistant to insulin’s command to stop releasing glucose, yet it remains responsive to insulin’s command to keep making fat. So you get the worst of both worlds: the liver overproduces glucose (raising blood sugar) while simultaneously overproducing fat (worsening the underlying problem).
When the Pancreas Begins to Fail
For years or even decades, your pancreas compensates for insulin resistance by simply making more insulin. This is stage one: you’re technically prediabetic or at risk, but your blood sugar stays normal because your pancreas is working overtime.
The trouble comes when the insulin-producing beta cells start to burn out. This happens in stages. First, blood sugar begins creeping above normal, settling into the prediabetic range. The beta cells lose some of their ability to respond quickly to a spike in blood sugar after a meal. Then comes a relatively rapid transition into full diabetes, as the beta cells lose more mass and become less specialized at their core job.
Fat plays a direct role here too. The fatty liver exports excess fat into the bloodstream as triglycerides. These triglycerides deliver fat to tissues throughout the body, including the pancreas. Chronic exposure to high levels of fat and glucose impairs the beta cells’ ability to secrete insulin in response to meals. In animal studies, sustained exposure of beta cells to saturated fat caused them to lose their rapid insulin response. The good news from reversal studies: when fat content in the pancreas drops, first-phase insulin response can gradually return to near-normal. But if beta cells have been damaged for too long, that recovery window closes permanently.
The Prediabetic Window
Type 2 diabetes doesn’t appear overnight. Population data shows that people typically spend 35 to 40 years in a state of normal blood sugar before transitioning to prediabetes. Once in the prediabetic range, the average time before progressing to diabetes is about 6 to 10 years, depending on which marker is elevated. People with mildly elevated fasting glucose tend to stay in that zone for roughly 10 years before progressing. Those with elevated post-meal glucose tend to progress faster, in about 6 years.
This long runway is both sobering and encouraging. It means the processes driving type 2 diabetes are operating silently for decades. But it also means there are years of opportunity to intervene before irreversible damage occurs.
Genetics Set the Threshold, Not the Outcome
Heritability estimates for type 2 diabetes run as high as 69% in European populations aged 35 to 60. That number sounds deterministic, but it’s misleading if taken at face value. What’s inherited isn’t diabetes itself but a lower threshold for developing it. Some people’s beta cells are more fragile. Some people’s bodies store fat in the liver and pancreas more readily than others, even at a relatively low body weight. This explains why some people develop type 2 diabetes without being significantly overweight, while others carry substantial excess weight and never do.
Hundreds of genetic variants contribute small amounts of risk. No single gene causes type 2 diabetes. Instead, you inherit a collection of vulnerabilities, and environmental factors determine whether those vulnerabilities get triggered. Gene-environment interactions remain one of the biggest gaps in predicting who will develop the disease.
Your Gut Bacteria Play a Supporting Role
The trillions of bacteria living in your digestive tract influence insulin sensitivity in ways researchers are still mapping out. The clearest connection runs through short-chain fatty acids, particularly butyrate and propionate, which are produced when gut bacteria ferment dietary fiber. Butyrate improves insulin sensitivity by activating receptors that help regulate glucose, and higher butyrate levels are associated with better insulin response. It also protects the insulin-producing beta cells by supporting their mitochondrial function and reducing cell death.
Specific bacterial species matter. People with lower levels of Akkermansia muciniphila, a gut bacterium that helps maintain the intestinal lining, show impaired insulin secretion. New-onset diabetes patients have significantly reduced levels of this bacterium. Meanwhile, bacteria that produce certain metabolites from the amino acid histidine appear to actively promote insulin resistance. People who eat more plant-based, fiber-rich diets tend to harbor higher levels of beneficial, short-chain fatty acid-producing bacteria like Faecalibacterium and Roseburia.
Putting the Pieces Together
Type 2 diabetes emerges from a collision between genetic susceptibility and metabolic overload. Chronic calorie surplus drives fat into the liver, which disrupts the liver’s ability to regulate glucose production. The liver exports that excess fat into the bloodstream, delivering it to the pancreas, where it gradually poisons the beta cells’ ability to secrete insulin. Visceral fat tissue fuels systemic inflammation that worsens insulin resistance in muscle and liver. The gut microbiome either buffers or amplifies these effects depending on its composition. And throughout all of this, the body compensates, sometimes for decades, until the beta cells can no longer keep up.
The root cause, then, is not sugar consumption, laziness, or any single dietary villain. It is a self-reinforcing cycle of excess fat in the wrong places, rising insulin demand, chronic inflammation, and eventual pancreatic exhaustion, unfolding on a timeline shaped by your genes and set in motion by sustained energy surplus.